{
    "2020-10-13": [
        [
            {
                "time": "2023-10-01",
                "original_text": "深布局大医药，高瓴“点金术”如何炼成？",
                "features": {
                    "keywords": [
                        "大医药",
                        "高瓴",
                        "点金术"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-02",
                "original_text": "医药CXO行业专题报告：赋能新药后起秀 行业高增前景优",
                "features": {
                    "keywords": [
                        "医药CXO",
                        "新药",
                        "高增前景"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-03",
                "original_text": "医药生物行业日报：严防二波疫情反复 板块行情反弹",
                "features": {
                    "keywords": [
                        "医药生物",
                        "二波疫情",
                        "板块行情反弹"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-04",
                "original_text": "高瓴资本概念股普遍活跃，公牛集团、金域医学、甘李药业、凯莱英等大涨",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "公牛集团",
                        "金域医学",
                        "甘李药业",
                        "凯莱英",
                        "大涨"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "海和药物启动上市进程，B轮融资规模达12亿美元",
                "features": {
                    "keywords": [
                        "海和药物",
                        "上市进程",
                        "B轮融资",
                        "12亿美元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-06",
                "original_text": "创新药物研发商海和药物启动上市进程 B轮融资规模达12亿美元",
                "features": {
                    "keywords": [
                        "创新药物",
                        "海和药物",
                        "上市进程",
                        "B轮融资",
                        "12亿美元"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-07",
                "original_text": "张磊又出手！10亿狂买医药大牛股",
                "features": {
                    "keywords": [
                        "张磊",
                        "医药",
                        "大牛股",
                        "10亿"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}